Assessing Veeva Systems: Insights From 27 Financial Analysts

Comments
Loading...

Throughout the last three months, 27 analysts have evaluated Veeva Systems VEEV, offering a diverse set of opinions from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 6 12 8 1 0
Last 30D 1 0 0 0 0
1M Ago 0 1 1 0 0
2M Ago 3 7 7 1 0
3M Ago 2 4 0 0 0

Insights from analysts' 12-month price targets are revealed, presenting an average target of $261.89, a high estimate of $307.00, and a low estimate of $195.00. This current average has increased by 5.24% from the previous average price target of $248.84.

price target chart

Deciphering Analyst Ratings: An In-Depth Analysis

The perception of Veeva Systems by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Ryan MacDonald Needham Maintains Buy $270.00 $270.00
Jailendra Singh Truist Securities Lowers Hold $210.00 $261.00
Scott Schoenhaus Keybanc Lowers Overweight $255.00 $285.00
Craig Hettenbach Morgan Stanley Raises Underweight $195.00 $183.00
Anne Samuel JP Morgan Raises Neutral $218.00 $208.00
Tyler Radke Citigroup Raises Buy $307.00 $281.00
Steven Valiquette Mizuho Raises Outperform $280.00 $275.00
Allan Verkhovski Scotiabank Raises Sector Perform $240.00 $235.00
Saket Kalia Barclays Raises Overweight $275.00 $260.00
Kirk Materne Evercore ISI Group Raises In-Line $245.00 $220.00
Brad Sills B of A Securities Raises Neutral $290.00 $280.00
Rishi Jaluria RBC Capital Raises Outperform $285.00 $275.00
David Grossman Stifel Raises Buy $272.00 $240.00
Stan Berenshteyn Wells Fargo Raises Overweight $285.00 $275.00
Jailendra Singh Truist Securities Raises Hold $261.00 $207.00
David Hynes Canaccord Genuity Raises Hold $270.00 $210.00
Joe Vruwink Baird Raises Outperform $283.00 $275.00
Ryan MacDonald Needham Raises Buy $270.00 $260.00
Brent Bracelin Piper Sandler Raises Overweight $290.00 $280.00
Steven Valiquette Mizuho Announces Outperform $275.00 -
Allan Verkhovski Scotiabank Announces Sector Perform $235.00 -
David Grossman Stifel Raises Buy $240.00 $210.00
Saket Kalia Barclays Raises Overweight $260.00 $240.00
Rishi Jaluria RBC Capital Raises Outperform $275.00 $250.00
Ryan MacDonald Needham Maintains Buy $260.00 $260.00
Brent Bracelin Piper Sandler Raises Overweight $280.00 $230.00
Joe Vruwink Baird Lowers Outperform $245.00 $251.00

Key Insights:

  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Veeva Systems. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Veeva Systems compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Veeva Systems's stock. This comparison reveals trends in analysts' expectations over time.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Veeva Systems's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Veeva Systems analyst ratings.

Unveiling the Story Behind Veeva Systems

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Veeva Systems's Economic Impact: An Analysis

Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.

Revenue Growth: Over the 3 months period, Veeva Systems showcased positive performance, achieving a revenue growth rate of 13.41% as of 31 October, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 26.57%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Veeva Systems's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.48%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Veeva Systems's ROA stands out, surpassing industry averages. With an impressive ROA of 2.91%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.

The Basics of Analyst Ratings

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Overview Rating:
Good
62.5%
Technicals Analysis
100
0100
Financials Analysis
40
0100
Overview
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!